Tetraphase Pharmaceuticals Inc - Company Profile

Powered by

All the sales intelligence you need on Tetraphase Pharmaceuticals Inc in one solution.

$ $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Tetraphase Pharmaceuticals Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Tetraphase Pharmaceuticals Inc.

Back to companies

Tetraphase Pharmaceuticals Inc: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

View up-to-date information on Tetraphase Pharmaceuticals Inc patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
CN110167560B Grant 四环素化合物和治疗方法 A61K2300/00; A61K31/65; A61K31/704; A61K31/7068; A61K45/06; A61P31/04; A61P35/00; A61P35/02; C07C2603/46; C07D205/04; C07D207/09; C07D209/94; C07D211/14; C07D217/04; C07D221/18; C07D231/54; C07D233/56; C07D295/15; C07D401/04; C07D401/06; C07D405/04; Y02A50/30 August 18, 2023
KR102558540B1 Grant 테트라사이클린 화합물 및 치료 방법 A61K2300/00; A61K31/65; A61K31/704; A61K31/7068; A61K45/06; A61P31/04; A61P35/00; A61P35/02; C07C2603/46; C07D205/04; C07D207/09; C07D209/94; C07D211/14; C07D217/04; C07D221/18; C07D231/54; C07D233/56; C07D295/15; C07D401/04; C07D401/06; C07D405/04; Y02A50/30 July 21, 2023
US20230122651A1 Application C7-fluoro substituted tetracycline compounds A61K31/65; A61K45/06; A61P31/00; A61P31/04; C07C233/57; C07C311/08; C07C311/21; C07D205/04; C07D207/06; C07D207/08; C07D207/09; C07D207/10; C07D207/12; C07D207/14; C07D207/16; C07D207/34; C07D209/94; C07D211/60; C07D211/76; C07D213/74; C07D213/81; C07D213/82; C07D231/12; C07D231/14; C07D231/56; C07D233/61; C07D239/42; C07D249/04; C07D257/04; C07D261/18; C07D261/20; C07D277/56; C07D295/088; C07D295/12; C07D295/15; C07D295/26; C07D311/08; C07D333/34; C07D333/38; C07D413/12; Y02A50/30 April 20, 2023
US11578044B2 Grant Crystalline forms of eravacycline A61P1/00; A61P1/02; A61P13/02; A61P31/00; A61P31/04; A61P35/00; A61P43/00; C07B2200/13; C07D207/06; C07D295/15 February 14, 2023
US20230031954A1 Application Tetracycline compounds and methods of treatment A61K31/65; A61P31/04; A61P35/00; A61P35/02; C07C2603/46; C07D205/04; C07D207/09; C07D209/94; C07D211/14; C07D217/04; C07D221/18; C07D231/54; C07D233/56; C07D295/15; C07D401/04; C07D401/06; C07D405/04; Y02A50/30 February 02, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer